A carregar...

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

Objective To evaluate the effect of the oral synthetic δ-9-tetrahydrocannabinol dronabinol on central neuropathic pain in patients with multiple sclerosis. Design Randomised double blind placebo controlled crossover trial. Setting Outpatient clinic, University Hospital of Aarhus, Denmark. Participan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Svendsen, Kristina B, Jensen, Troels S, Bach, Flemming W
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group Ltd. 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC498019/
https://ncbi.nlm.nih.gov/pubmed/15258006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.38149.566979.AE
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!